Neuvivo
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. Neuvivo is investigating a patented macrophage-targeted technology, NP001, designed to address chronic inflammation, a key factor in the progressive loss of motor function in ALS.
Geography: USA